OpenAI’s CEO Sam Altman was the star speaker of the summit. The FDA is poised to approve the notorious party drug as a therapy.
US FDA staff raises ... use of the drug for the first time. EU regulator backs use of Pfizer's gene therapy for rare bleeding ...
This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
The Food and Drug Administration has approved giving GSK's vaccine ... the first shot greenlit for use in this age group to guard against RSV. Global vaccine and drugmaker GSK asked the FDA ...
has recommended granting conditional marketing authorization in the EU to Pfizer's hemophilia B gene therapy Durveqtix ...
The FDA's expanded approval could help GSK maintain its dominance in the RSV market, which includes shots from Pfizer and Moderna. The shot, called Arexvy, is the first vaccine cleared by the FDA ...
“Gene therapy is a one-time treatment ... who also serves as Pfizer’s chief development officer of internal medicine and ...
EU publishes its first list ... The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle ...
Geron's CEO said the company anticipates a peak market potential of $1.2 billion in the US and some key EU countries by 2030. In March, by a 12-to-2 margin, the FDA adcomm panel voted in favor of ...
The Singapore Health Sciences Authority (HSA) has approved its 20-valent pneumococcal conjugate vaccine (PCV20) that protects against invasive pneumococcal disease and pneumonia caused by 20 ...
Primary hemochromatosis is inherited and caused by gene alterations ... the body’s absorption and elimination of iron might ...